Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 3Melanoma 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Squamous Intraepithelial Lesions 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Prostate Adenocarcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Liver Diseases 1Liposarcoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Breast Neoplasms 1

Interventions

VGX-3100 4Light Coagulation 3DNA Methylation 3Colposcopy 3Biopsy 3Watchful Waiting 2Polymerase Chain Reaction 2Observation 2Laser Therapy 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1calcipotriene 1Solutions 1Restraint, Physical 1Red Light 1Radiofrequency Ablation 1Probiotics 1Mindfulness-Based Stress Reduction 1Megestrol Acetate 1Mass Screening 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × Adjuvants, Pharmaceutic × Clear all
NCT02576561 2017-10-25

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

THEVAX Genetics Vaccine

Phase 2 Unknown
10 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡